Corrigendum to “Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile” [Pharmacol. Res. (2016) 110(2016) (205–215)] (S1043661816302080) (10.1016/j.phrs.2016.03.021)
ISSN
10436618
Date Issued
2017
Author(s)
DOI
10.1016/j.phrs.2017.04.002
Subjects